安永維持香港全年新股集資額在約2,000億元不變
安永亞太區上市服務主管蔡偉榮在記者會上表示,雖然預料阿里巴巴將會在下半年來港作第二上市,但仍維持本港全年新股集資額在2,000億元不變,形容此估算較為保守,主要是因為貿易戰為全球投資氣氛帶來不確定性,加上內地科創板成功推出後,一些高科技企業或會選擇到上海上市,而且香港市場對小型IPO監管加強。
他相信,今年香港集資額仍有望維持全球首三位,但由於目前與紐交所的集資額仍有一段距離,加上下半年美國市場仍熾熱,因此要重回第一位有難度。
蔡偉榮又指,若阿里巴巴來港上市,並取得成功,或有機會令京東及百度等科技企業仿傚來港上市。他提到,科技公司是全球寵兒,因此交易所間的競爭很大,但認為香港的地位在亞太區仍高,對投資者而言仍有一定吸引力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.